Cite
APA Citation
Urun, Y., Abal, H., Turna, H., Esin, E., Sedef, A., Alkan, A., Oksüzoğlu, B., Ozdemir, N., Sendur, M., Sezer, A., Kiliçkap, S., Akbulut, H., & Celik, I. (n.d.). 3354 Prognostic factors for survival in patients with metastatic melanoma treated with ipilimumab: Turkish Oncology Group (TOG) Study. European journal of cancer, 51, S686–S687. http://access.bl.uk/ark:/81055/vdc_100030687863.0x00005e